Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus.

Autor:	Trevillyan JM; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles.; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia., Moser C; Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Currier JS; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles., Sallam T; Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Apr 10; Vol. 70 (8), pp. 1764-1767.
DOI:	10.1093/cid/ciz765
Abstrakt:	In a retrospective case control analysis, following adjustments for high-sensitivity C-reactive protein (hsCRP), traditional cardiovascular risk factors, and the CD4/CD8 T-cell ratio, higher lipopolysaccharide-binding protein (LBP) was associated with future myocardial infarctions in hsCRP human immunodeficiency virus (HIV). LBP may be a marker of cardiovascular risk with utility in HIV. (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu